Efficacy and safety of immune checkpoint inhibitors plus chemotherapy in esophageal cancer patients with liver metastases
For EC patients with liver metastases, the combination of CMT and ICIs demonstrates significantly superior efficacy compared with CMT alone, while maintaining manageable TRAEs.
Authors
- Yuetong Li (ORCID: https://orcid.org/0009-0004-0320-0953)
- Wei Feng
- Shu-Hao Que
- En-Hui Dai
- Huan Xu
- Guo-Qiang Zhong
- Zhen Zhang
- Shu-Wei Zhai
- Jing-Jing Wang
- Xu Liang
Institutions
- Hebei University of Engineering (CN)
- Hebei Medical University (CN)
- Zhejiang Chinese Medical University (CN)
- Jiangsu University (CN)
- Zhejiang Provincial Hospital of TCM (CN)
- Zhejiang Cancer Hospital (CN)
- The First People's Hospital of Changzhou (CN)
- Zhejiang Hospital (CN)
- Jintan People's Hospital (CN)
- Yancheng Third People's Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
- Maastro Clinic (NL)
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.4251/wjgo.v18.i1.113440
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00